Aclasta

In the US, Aclasta (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis and Paget's Disease.

US matches:

• Aclasta

UK matches:

• Aclasta 5 mg solution for infusion (SPC)

Ingredient matches for Aclasta

Zoledronic Acid

Zoledronic Acid is reported as an ingredient of Aclasta in the following countries:

• Canada


• Denmark


• Indonesia


• New Zealand


• Peru


• Russian Federation


• Slovenia


• United Kingdom


• Venezuela

Zoledronic Acid monohydrate (a derivative of Zoledronic Acid) is reported as an ingredient of Aclasta in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Bulgaria


• Croatia (Hrvatska)


• Czech Republic


• Ecuador


• Finland


• France


• Georgia


• Germany


• Greece


• Hungary


• Iceland


• Ireland


• Italy


• Luxembourg


• Netherlands


• Norway


• Portugal


• Romania


• Slovakia


• South Africa


• Spain


• Sweden


• Switzerland

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.